14q11.2 microduplication syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
14q12 microdeletion syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
Abnormal CNS myelination
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Abnormal corpus callosum morphology
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormal involuntary movement
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Abnormal involuntary movements are a major feature of FOXG1 mutations.
|
27029630 |
2016 |
Abnormality of brain morphology
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of the antihelix
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the antitragus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the metacarpal bones
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the optic nerve
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Absence Seizures
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features.
|
18627055 |
2008 |
Absent speech
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Absent speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acid reflux
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Acrocallosal Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features.
|
18627055 |
2008 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.
|
28465359 |
2017 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma.
|
30172378 |
2018 |
Adult Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our findings are consistent with a role for FOXG1 in the inhibition of TGF-beta induced cytostasis in medulloblastoma.
|
17522785 |
2007 |
Adult Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
|
23592496 |
2013 |
Agenesis of corpus callosum
|
0.120 |
Biomarker
|
disease |
BEFREE |
FOXG1B (forkhead box G1B) is a very intriguing candidate gene since it is known to promote neuronal progenitor proliferation and to suppress premature neurogenesis and its disruption is reported in a patient with postnatal microcephaly, corpus callosum agenesis, seizures, and severe mental retardation.
|
18627055 |
2008 |
Agenesis of corpus callosum
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Agenesis of corpus callosum
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
We also found that inactivation of one Foxg1 allele specifically in cortical neurons was sufficient to cause cerebral cortical hypoplasia and corpus callosum agenesis.
|
30392794 |
2018 |
Angelman Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Among these are classic disorders such as Angelman syndrome and MECP2-related disorder (formerly Rett syndrome), as well as more recently described clinical entities associated with mutations in CASK, CDKL5, CREBBP, and EP300 (Rubinstein-Taybi syndrome), FOXG1, SLC9A6 (Christianson syndrome), and TCF4 (Pitt-Hopkins syndrome).
|
24839169 |
2014 |
Anxiety
|
0.010 |
Biomarker
|
disease |
BEFREE |
Patients suffering from FOXG1-related disorders exhibit severe anxiety, sleep disturbance and choroid plexus cysts, indicating that Foxg1 likely plays a role in epithalamic development.
|
29394901 |
2018 |
Anxiety Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Patients suffering from FOXG1-related disorders exhibit severe anxiety, sleep disturbance and choroid plexus cysts, indicating that Foxg1 likely plays a role in epithalamic development.
|
29394901 |
2018 |